Fertility Services Market-Global Industry Analysis and forecast (2022-2029)


Fertility Services Market is expected to reach US$ 41.75 Bn. at a CAGR of 6.2% during the forecast period 2029.

Fertility Services Market

To know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Fertility services are procedures or treatments used to cure genetic & fertility issues and help with conception. These services help reproductive technology (ART) methods and drugs, which in turn help infertile couples in planning a family. The Global Fertility Services market is driven by the continuous declining fertility rates and rising number of fertility clinics worldwide. Delayed pregnancies in women and technological advancements regarding fertility treatment in the industry are also projected to impel the market growth in the forecast period.

However, the high treatment cost of assisted reproductive techniques in developed countries and unsupportive government regulations are restraining the market growth at the global level. Improving healthcare infrastructure and increasing medical tourism due to low treatment costs are expected to create beneficial opportunities for the key player in the market during the forecast period. Concerns related to art procedures are the major challenge for the Fertility Services market in the near future.

Based on the type, the fertility clinic segment has led the fertility services market in 2021 and is estimated to generate more than US$ xx Mn market revenue by 2027, with a CAGR of xx%. Due to the constant rise in the number of fertility clinics, the high success rate of fertility treatment in clinics because of the adoption of advanced technology, tie-ups of clinics with consultants, and rising fertility tourism. But, the hospital segment is expected to witness a growth rate of xx% during the forecast period owing to advanced procedures and equipment, availability of expert doctors, and ongoing research in hospitals for improving the success rate of the ART treatment.

Geographically, the Fertility Services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe held the prominent market share of xx% in 2021 and is expected to reach US$ Mn by the end of 2027, with a CAGR of xx%. Thanks to the lower fertility rate and growth in the median age of motherhood in the region. Additionally, growing obesity cases and increasing IVF tourism in Spain is likely to fuel the market growth in Europe.

North America held the second-largest market share of xx% in 2021 and is expected to grow at the CAGR of xx% forecast period owing to the declining fertility rates, increase in healthcare expenditure, and the presence of major players in this region. Also, the high adoption rate of IVF treatment will impel the market growth in the region. The market in Asia Pacific is expected to grow at a high CAGR of xx% during the forecast period thanks to the decreasing fertility rates in the region. The delay in pregnancy in women suffering from gynecological conditions is also positively affecting market growth.

A report covers the recent development in market for the global fertility services market e.g., in November 2018, INVO Bioscience and Ferring pharmaceuticals entered into an U.S. licensing agreement for commercializing the new invocell system to utilize it in the infertility treatment.

The objective of the report is to present a comprehensive analysis of the Global Fertility Services Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Fertility Services Market dynamics, structure by analyzing the market segments and project the Global Fertility Services Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Fertility Services Market make the report investor’s guide.

Fertility Services Market Scope: Inquire before buying


Fertility Services Market, by Procedure:

• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Others

Fertility Services Market, by Service:

• Fresh Non-donor
• Frozen Non-donor
• Egg & Embryo Banking
• Fresh Donor
• Frozen Donor

Fertility Services Market, by End Users:

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

Fertility Services Market, by Region:

• Asia Pacific
• North America
• Europe
• Latin America
• Middle East Africa

Fertility Services Market, Key Players:

• Apollo Hospitals Enterprise Ltd.
• Care Fertility Group
• Carolinas Fertility Institute
• Genea Limited
• The Johns Hopkins Health System Corp
• Medicover Group
• Monash IVF Group
• OvaScience Inc.
• Progyny Inc.
• Xytex Cryo International
• Irvine Scientific
• INVO Bioscience
• LifeGlobal Group
• IVFtech ApS.
• Merck KGaA
• CooperSurgical, Inc.
• Care Fertility
• Ferring B.V.
• Vitrolife
• Olympus Corporation
• Instituto Bernabeu
• Virtus Health
• Fertility Focus
• LABOTECT GMBH
• CryoChoice, LLC.
• Millendo Therapeutics, Inc.
• FUJIFILM Irvine Scientific

Frequently Asked Questions:

1. Which region has the largest share in Global Fertility Services Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Fertility Services Market?
Ans: The Global Fertility Services Market is growing at a CAGR of 6.2% during forecasting period 2022-2029.

3. What is scope of the Global Fertility Services market report?
Ans: Global Fertility Services Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Fertility Services market?
Ans: The important key players in the Global Fertility Services Market are – Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., Xytex Cryo International, Irvine Scientific, INVO Bioscience, LifeGlobal Group, IVFtech ApS., Merck KGaA, CooperSurgical, Inc., Care Fertility, Ferring B.V., Vitrolife, Olympus Corporation, Instituto Bernabeu, Virtus Health, Fertility Focus, LABOTECT GMBH, CryoChoice, LLC., Millendo Therapeutics, Inc., and FUJIFILM Irvine Scientific

5. What is the study period of this market?
Ans: The Global Fertility Services Market is studied from 2021 to 2029. 




Global Fertility Services Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Fertility Services Market Size, by Market Value (US$ Mn )
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Fertility Services Market Analysis and Forecast
6.1. Global Fertility Services Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Fertility Services Market Analysis and Forecast, by Procedure
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Fertility Services Market Value Share Analysis, by Procedure
7.4. Global Fertility Services Market Size (US$ Mn ) Forecast, by Procedure
7.5. Global Fertility Services Market Analysis, by Procedure
7.6. Global Fertility Services Market Attractiveness Analysis, by Procedure

8. Global Fertility Services Market Analysis and Forecast, by Service
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Fertility Services Market Value Share Analysis, by Service
8.4. Global Fertility Services Market Size (US$ Mn ) Forecast, by Service
8.5. Global Fertility Services Market Analysis, by Service
8.6. Global Fertility Services Market Attractiveness Analysis, by Service

9. Global Fertility Services Market Analysis and Forecast, by End-User
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Fertility Services Market Value Share Analysis, by End-User
9.4. Global Fertility Services Market Size (US$ Mn) Forecast, by End-User
9.5. Global Fertility Services Market Analysis, by End-User
9.6. Global Fertility Services Market Attractiveness Analysis, by End-User

10. Global Fertility Services Market Analysis, by Region
10.1. Global Fertility Services Market Value Share Analysis, by Region
10.2. Global Fertility Services Market Size (US$ Mn) Forecast, by Region
10.3. Global Fertility Services Market Attractiveness Analysis, by Region

11. North America Fertility Services Market Analysis
11.1. Key Findings
11.2. North America Fertility Services Market Overview
11.3. North America Fertility Services Market Value Share Analysis, by Procedure
11.4. North America Fertility Services Market Forecast, by Procedure
11.4.1. IVF with ICSI
11.4.2. IUI
11.4.3. IVF without ICSI
11.4.4. Surrogacy
11.4.5. Others
11.5. North America Fertility Services Market Value Share Analysis, by Service
11.6. North America Fertility Services Market Forecast, by Service
11.6.1. Fresh Non-donor
11.6.2. Frozen Non-donor
11.6.3. Egg & Embryo Banking
11.6.4. Fresh Donor
11.6.5. Frozen Donor
11.7. North America Fertility Services Market Value Share Analysis, by End-User
11.8. North America Fertility Services Market Forecast, by End-User
11.8.1. Fertility Clinics
11.8.2. Hospitals
11.8.3. Surgical Centers
11.8.4. Clinical Research Institutes
11.9. North America Fertility Services Market Value Share Analysis, by Country
11.10. North America Fertility Services Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Fertility Services Market Analysis, by Country
11.12. U.S. Fertility Services Market Forecast, by Procedure
11.12.1. IVF with ICSI
11.12.2. IUI
11.12.3. IVF without ICSI
11.12.4. Surrogacy
11.12.5. Others
11.13. U.S. Fertility Services Market Forecast, by Service
11.13.1. Fresh Non-donor
11.13.2. Frozen Non-donor
11.13.3. Egg & Embryo Banking
11.13.4. Fresh Donor
11.13.5. Frozen Donor
11.14. U.S. Fertility Services Market Forecast, by End-User
11.14.1. Fertility Clinics
11.14.2. Hospitals
11.14.3. Surgical Centers
11.14.4. Clinical Research Institutes
11.15. Canada Fertility Services Market Forecast, by Procedure
11.15.1. IVF with ICSI
11.15.2. IUI
11.15.3. IVF without ICSI
11.15.4. Surrogacy
11.15.5. Others
11.16. Canada Fertility Services Market Forecast, by Service
11.16.1. Fresh Non-donor
11.16.2. Frozen Non-donor
11.16.3. Egg & Embryo Banking
11.16.4. Fresh Donor
11.16.5. Frozen Donor
11.17. Canada Fertility Services Market Forecast, by End-User
11.17.1. Fertility Clinics
11.17.2. Hospitals
11.17.3. Surgical Centers
11.17.4. Clinical Research Institutes
11.18. North America Fertility Services Market Attractiveness Analysis
11.18.1. By Procedure
11.18.2. By Service
11.18.3. By End-User
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Fertility Services Market Analysis
12.1. Key Findings
12.2. Europe Fertility Services Market Overview
12.3. Europe Fertility Services Market Value Share Analysis, by Procedure
12.4. Europe Fertility Services Market Forecast, by Procedure
12.4.1. IVF with ICSI
12.4.2. IUI
12.4.3. IVF without ICSI
12.4.4. Surrogacy
12.4.5. Others
12.5. Europe Fertility Services Market Value Share Analysis, by Service
12.6. Europe Fertility Services Market Forecast, by Service
12.6.1. Fresh Non-donor
12.6.2. Frozen Non-donor
12.6.3. Egg & Embryo Banking
12.6.4. Fresh Donor
12.6.5. Frozen Donor
12.7. Europe Fertility Services Market Value Share Analysis, by End-User
12.8. Europe Fertility Services Market Forecast, by End-User
12.8.1. Fertility Clinics
12.8.2. Hospitals
12.8.3. Surgical Centers
12.8.4. Clinical Research Institutes
12.9. Europe Fertility Services Market Value Share Analysis, by Country
12.10. Europe Fertility Services Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Fertility Services Market Analysis, by Country
12.12. Germany Fertility Services Market Forecast, by Procedure
12.12.1. IVF with ICSI
12.12.2. IUI
12.12.3. IVF without ICSI
12.12.4. Surrogacy
12.12.5. Others
12.13. Germany Fertility Services Market Forecast, by Service
12.13.1. Fresh Non-donor
12.13.2. Frozen Non-donor
12.13.3. Egg & Embryo Banking
12.13.4. Fresh Donor
12.13.5. Frozen Donor
12.14. Germany Fertility Services Market Forecast, by End-User
12.14.1. Fertility Clinics
12.14.2. Hospitals
12.14.3. Surgical Centers
12.14.4. Clinical Research Institutes
12.15. U.K. Fertility Services Market Forecast, by Procedure
12.15.1. IVF with ICSI
12.15.2. IUI
12.15.3. IVF without ICSI
12.15.4. Surrogacy
12.15.5. Others
12.16. U.K. Fertility Services Market Forecast, by Service
12.16.1. Fresh Non-donor
12.16.2. Frozen Non-donor
12.16.3. Egg & Embryo Banking
12.16.4. Fresh Donor
12.16.5. Frozen Donor
12.17. U.K. Fertility Services Market Forecast, by End-User
12.17.1. Fertility Clinics
12.17.2. Hospitals
12.17.3. Surgical Centers
12.17.4. Clinical Research Institutes
12.18. France Fertility Services Market Forecast, by Procedure
12.18.1. IVF with ICSI
12.18.2. IUI
12.18.3. IVF without ICSI
12.18.4. Surrogacy
12.18.5. Others
12.19. France Fertility Services Market Forecast, by Service
12.19.1. Fresh Non-donor
12.19.2. Frozen Non-donor
12.19.3. Egg & Embryo Banking
12.19.4. Fresh Donor
12.19.5. Frozen Donor
12.20. France Fertility Services Market Forecast, by End-User
12.20.1. Fertility Clinics
12.20.2. Hospitals
12.20.3. Surgical Centers
12.20.4. Clinical Research Institutes
12.21. Italy Fertility Services Market Forecast, by Procedure
12.21.1. IVF with ICSI
12.21.2. IUI
12.21.3. IVF without ICSI
12.21.4. Surrogacy
12.21.5. Others
12.22. Italy Fertility Services Market Forecast, by Service
12.22.1. Fresh Non-donor
12.22.2. Frozen Non-donor
12.22.3. Egg & Embryo Banking
12.22.4. Fresh Donor
12.22.5. Frozen Donor
12.23. Italy Fertility Services Market Forecast, by End-User
12.23.1. Fertility Clinics
12.23.2. Hospitals
12.23.3. Surgical Centers
12.23.4. Clinical Research Institutes
12.24. Spain Fertility Services Market Forecast, by Procedure
12.24.1. IVF with ICSI
12.24.2. IUI
12.24.3. IVF without ICSI
12.24.4. Surrogacy
12.24.5. Others
12.25. Spain Fertility Services Market Forecast, by Service
12.25.1. Fresh Non-donor
12.25.2. Frozen Non-donor
12.25.3. Egg & Embryo Banking
12.25.4. Fresh Donor
12.25.5. Frozen Donor
12.26. Spain Fertility Services Market Forecast, by End-User
12.26.1. Fertility Clinics
12.26.2. Hospitals
12.26.3. Surgical Centers
12.26.4. Clinical Research Institutes
12.27. Rest of Europe Fertility Services Market Forecast, by Procedure
12.27.1. IVF with ICSI
12.27.2. IUI
12.27.3. IVF without ICSI
12.27.4. Surrogacy
12.27.5. Others
12.28. Rest of Europe Fertility Services Market Forecast, by Service
12.28.1. Fresh Non-donor
12.28.2. Frozen Non-donor
12.28.3. Egg & Embryo Banking
12.28.4. Fresh Donor
12.28.5. Frozen Donor
12.29. Rest of Europe Fertility Services Market Forecast, by End-User
12.29.1. Fertility Clinics
12.29.2. Hospitals
12.29.3. Surgical Centers
12.29.4. Clinical Research Institutes
12.30. Europe Fertility Services Market Attractiveness Analysis
12.30.1. By Procedure
12.30.2. By Service
12.30.3. By End User
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments

13. Asia Pacific Fertility Services Market Analysis
13.1. Key Findings
13.2. Asia Pacific Fertility Services Market Overview
13.3. Asia Pacific Fertility Services Market Value Share Analysis, by Procedure
13.4. Asia Pacific Fertility Services Market Forecast, by Procedure
13.4.1. IVF with ICSI
13.4.2. IUI
13.4.3. IVF without ICSI
13.4.4. Surrogacy
13.4.5. Others
13.5. Asia Pacific Fertility Services Market Value Share Analysis, by Service
13.6. Asia Pacific Fertility Services Market Forecast, by Service
13.6.1. Fresh Non-donor
13.6.2. Frozen Non-donor
13.6.3. Egg & Embryo Banking
13.6.4. Fresh Donor
13.6.5. Frozen Donor
13.7. Asia Pacific Fertility Services Market Value Share Analysis, by End-User
13.8. Asia Pacific Fertility Services Market Forecast, by End-User
13.8.1. Fertility Clinics
13.8.2. Hospitals
13.8.3. Surgical Centers
13.8.4. Clinical Research Institutes
13.9. Asia Pacific Fertility Services Market Value Share Analysis, by Country
13.10. Asia Pacific Fertility Services Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Fertility Services Market Analysis, by Country
13.12. China Fertility Services Market Forecast, by Procedure
13.12.1. IVF with ICSI
13.12.2. IUI
13.12.3. IVF without ICSI
13.12.4. Surrogacy
13.12.5. Others
13.13. China Fertility Services Market Forecast, by Service
13.13.1. Fresh Non-donor
13.13.2. Frozen Non-donor
13.13.3. Egg & Embryo Banking
13.13.4. Fresh Donor
13.13.5. Frozen Donor
13.14. China Fertility Services Market Forecast, by End-User
13.14.1. Fertility Clinics
13.14.2. Hospitals
13.14.3. Surgical Centers
13.14.4. Clinical Research Institutes
13.15. India Fertility Services Market Forecast, by Procedure
13.15.1. IVF with ICSI
13.15.2. IUI
13.15.3. IVF without ICSI
13.15.4. Surrogacy
13.15.5. Others
13.16. India Fertility Services Market Forecast, by Service
13.16.1. Fresh Non-donor
13.16.2. Frozen Non-donor
13.16.3. Egg & Embryo Banking
13.16.4. Fresh Donor
13.16.5. Frozen Donor
13.17. India Fertility Services Market Forecast, by End-User
13.17.1. Fertility Clinics
13.17.2. Hospitals
13.17.3. Surgical Centers
13.17.4. Clinical Research Institutes
13.18. Japan Fertility Services Market Forecast, by Procedure
13.18.1. IVF with ICSI
13.18.2. IUI
13.18.3. IVF without ICSI
13.18.4. Surrogacy
13.18.5. Others
13.19. Japan Fertility Services Market Forecast, by Service
13.19.1. Fresh Non-donor
13.19.2. Frozen Non-donor
13.19.3. Egg & Embryo Banking
13.19.4. Fresh Donor
13.19.5. Frozen Donor
13.20. Japan Fertility Services Market Forecast, by End-User
13.20.1. Fertility Clinics
13.20.2. Hospitals
13.20.3. Surgical Centers
13.20.4. Clinical Research Institutes
13.21. ASEAN Fertility Services Market Forecast, by Procedure
13.21.1. IVF with ICSI
13.21.2. IUI
13.21.3. IVF without ICSI
13.21.4. Surrogacy
13.21.5. Others
13.22. ASEAN Fertility Services Market Forecast, by Service
13.22.1. Fresh Non-donor
13.22.2. Frozen Non-donor
13.22.3. Egg & Embryo Banking
13.22.4. Fresh Donor
13.22.5. Frozen Donor
13.23. ASEAN Fertility Services Market Forecast, by End-User
13.23.1. Fertility Clinics
13.23.2. Hospitals
13.23.3. Surgical Centers
13.23.4. Clinical Research Institutes
13.24. Rest of Asia Pacific Fertility Services Market Forecast, by Procedure
13.24.1. IVF with ICSI
13.24.2. IUI
13.24.3. IVF without ICSI
13.24.4. Surrogacy
13.24.5. Others
13.25. Rest of Asia Pacific Fertility Services Market Forecast, by Service
13.25.1. Fresh Non-donor
13.25.2. Frozen Non-donor
13.25.3. Egg & Embryo Banking
13.25.4. Fresh Donor
13.25.5. Frozen Donor
13.26. Rest of Asia Pacific Fertility Services Market Forecast, by End-User
13.26.1. Fertility Clinics
13.26.2. Hospitals
13.26.3. Surgical Centers
13.26.4. Clinical Research Institutes
13.27. Asia Pacific Fertility Services Market Attractiveness Analysis
13.27.1. By Procedure
13.27.2. By Service
13.27.3. By End-User
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments

14. Middle East & Africa Fertility Services Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Fertility Services Market Overview
14.3. Middle East & Africa Fertility Services Market Value Share Analysis, by Procedure
14.4. Middle East & Africa Fertility Services Market Forecast, by Procedure
14.4.1. IVF with ICSI
14.4.2. IUI
14.4.3. IVF without ICSI
14.4.4. Surrogacy
14.4.5. Others
14.5. Middle East & Africa Fertility Services Market Value Share Analysis, by Service
14.6. Middle East & Africa Fertility Services Market Forecast, by Service
14.6.1. Fresh Non-donor
14.6.2. Frozen Non-donor
14.6.3. Egg & Embryo Banking
14.6.4. Fresh Donor
14.6.5. Frozen Donor
14.7. Middle East & Africa Fertility Services Market Value Share Analysis, by End-User
14.8. Middle East & Africa Fertility Services Market Forecast, by End-User
14.8.1. Fertility Clinics
14.8.2. Hospitals
14.8.3. Surgical Centers
14.8.4. Clinical Research Institutes
14.9. Middle East & Africa Fertility Services Market Value Share Analysis, by Country
14.10. Middle East & Africa Fertility Services Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Fertility Services Market Analysis, by Country
14.12. GCC Fertility Services Market Forecast, by Procedure
14.12.1. IVF with ICSI
14.12.2. IUI
14.12.3. IVF without ICSI
14.12.4. Surrogacy
14.12.5. Others
14.13. GCC Fertility Services Market Forecast, by Service
14.13.1. Fresh Non-donor
14.13.2. Frozen Non-donor
14.13.3. Egg & Embryo Banking
14.13.4. Fresh Donor
14.13.5. Frozen Donor
14.14. GCC Fertility Services Market Forecast, by End-User
14.14.1. Fertility Clinics
14.14.2. Hospitals
14.14.3. Surgical Centers
14.14.4. Clinical Research Institutes
14.15. South Africa Fertility Services Market Forecast, by Procedure
14.15.1. IVF with ICSI
14.15.2. IUI
14.15.3. IVF without ICSI
14.15.4. Surrogacy
14.16. South Africa Fertility Services Market Forecast, by Service
14.16.1. Fresh Non-donor
14.16.2. Frozen Non-donor
14.16.3. Egg & Embryo Banking
14.16.4. Fresh Donor
14.16.5. Frozen Donor
14.17. South Africa Fertility Services Market Forecast, by End-User
14.17.1. Fertility Clinics
14.17.2. Hospitals
14.17.3. Surgical Centers
14.17.4. Clinical Research Institutes
14.18. Rest of Middle East & Africa Fertility Services Market Forecast, by Procedure
14.18.1. IVF with ICSI
14.18.2. IUI
14.18.3. IVF without ICSI
14.18.4. Surrogacy
14.18.5. Others
14.19. Rest of Middle East & Africa Fertility Services Market Forecast, by Service
14.19.1. Fresh Non-donor
14.19.2. Frozen Non-donor
14.19.3. Egg & Embryo Banking
14.19.4. Fresh Donor
14.19.5. Frozen Donor
14.20. Rest of Middle East & Africa Fertility Services Market Forecast, by End-User
14.20.1. Fertility Clinics
14.20.2. Hospitals
14.20.3. Surgical Centers
14.20.4. Clinical Research Institutes
14.21. Middle East & Africa Fertility Services Market Attractiveness Analysis
14.21.1. By Procedure
14.21.2. By Service
14.21.3. By End User
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Fertility Services Market Analysis
15.1. Key Findings
15.2. South America Fertility Services Market Overview
15.3. South America Fertility Services Market Value Share Analysis, by Procedure
15.4. South America Fertility Services Market Forecast, by Procedure
15.4.1. IVF with ICSI
15.4.2. IUI
15.4.3. IVF without ICSI
15.4.4. Surrogacy
15.4.5. Others
15.5. South America Fertility Services Market Value Share Analysis, by Service
15.6. South America Fertility Services Market Forecast, by Service
15.6.1. Fresh Non-donor
15.6.2. Frozen Non-donor
15.6.3. Egg & Embryo Banking
15.6.4. Fresh Donor
15.6.5. Frozen Donor
15.7. South America Fertility Services Market Value Share Analysis, by End-User
15.8. South America Fertility Services Market Forecast, by End-User
15.8.1. Fertility Clinics
15.8.2. Hospitals
15.8.3. Surgical Centers
15.8.4. Clinical Research Institutes
15.9. South America Fertility Services Market Value Share Analysis, by Country
15.10. South America Fertility Services Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Fertility Services Market Analysis, by Country
15.12. Brazil Fertility Services Market Forecast, by Procedure
15.12.1. IVF with ICSI
15.12.2. IUI
15.12.3. IVF without ICSI
15.12.4. Surrogacy
15.12.5. Others
15.13. Brazil Fertility Services Market Forecast, by Service
15.13.1. Fresh Non-donor
15.13.2. Frozen Non-donor
15.13.3. Egg & Embryo Banking
15.13.4. Fresh Donor
15.13.5. Frozen Donor
15.14. Brazil Fertility Services Market Forecast, by End-User
15.14.1. Fertility Clinics
15.14.2. Hospitals
15.14.3. Surgical Centers
15.14.4. Clinical Research Institutes
15.15. Mexico Fertility Services Market Forecast, by Procedure
15.15.1. IVF with ICSI
15.15.2. IUI
15.15.3. IVF without ICSI
15.15.4. Surrogacy
15.15.5. Others
15.16. Mexico Fertility Services Market Forecast, by Service
15.16.1. Fresh Non-donor
15.16.2. Frozen Non-donor
15.16.3. Egg & Embryo Banking
15.16.4. Fresh Donor
15.16.5. Frozen Donor
15.17. Mexico Fertility Services Market Forecast, by End-User
15.17.1. Fertility Clinics
15.17.2. Hospitals
15.17.3. Surgical Centers
15.17.4. Clinical Research Institutes
15.18. Rest of South America Fertility Services Market Forecast, by Procedure
15.18.1. IVF with ICSI
15.18.2. IUI
15.18.3. IVF without ICSI
15.18.4. Surrogacy
15.18.5. Others
15.19. Rest of South America Fertility Services Market Forecast, by Service
15.19.1. Fresh Non-donor
15.19.2. Frozen Non-donor
15.19.3. Egg & Embryo Banking
15.19.4. Fresh Donor
15.19.5. Frozen Donor
15.20. Rest of South America Fertility Services Market Forecast, by End-User
15.20.1. Fertility Clinics
15.20.2. Hospitals
15.20.3. Surgical Centers
15.20.4. Clinical Research Institutes
15.21. South America Fertility Services Market Attractiveness Analysis
15.21.1. By Procedure
15.21.2. By Service
15.21.3. By End User
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Apollo Hospitals Enterprise Ltd.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2. Care Fertility Group
16.3.3. Carolinas Fertility Institute
16.3.4. Genea Limited
16.3.5. The Johns Hopkins Health System Corp
16.3.6. Medicover Group
16.3.7. Monash IVF Group
16.3.8. OvaScience Inc.
16.3.9. Progyny Inc.
16.3.10. Xytex Cryo International
16.3.11. Irvine Scientific
16.3.12. INVO Bioscience
16.3.13. LifeGlobal Group
16.3.14. IVFtech ApS.
16.3.15. Merck KGaA
16.3.16. CooperSurgical, Inc.
16.3.17. Care Fertility
16.3.18. Ferring B.V.
16.3.19. Vitrolife
16.3.20. Olympus Corporation
16.3.21. Instituto Bernabeu
16.3.22. Virtus Health
16.3.23. Fertility Focus
16.3.24. LABOTECT GMBH
16.3.25. CryoChoice, LLC.
16.3.26. Millendo Therapeutics, Inc.
16.3.27. FUJIFILM Irvine Scientific
17. Primary Key Insights
  • INQUIRE BEFORE BUYING